AKAP9 Antikörper (AA 17-130)

Produktnummer ABIN968571

Produktdetails anti-AKAP9 Antikörper

Target: AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))

Bindungsspezifität: AA 17-130

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser AKAP9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF)

Produktmerkmale: 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.

Aufreinigung: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogen: Human AKAP450 aa. 17-130

Klon: 7-AKAP450

Isotyp: IgG1

Anwendungsinformationen

Kommentare:

Related Products: ABIN968537, ABIN967389

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 250 μg/mL

Buffer: Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store undiluted at -20°C.

Referenzen für anti-AKAP9 Antikörper (ABIN968571)

Westphal, Tavalin, Lin, Alto, Fraser, Langeberg, Sheng, Scott: "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex." in: Science (New York, N.Y.), Vol. 285, Issue 5424, pp. 93-6, (1999) (PubMed).

Witczak, Skålhegg, Keryer, Bornens, Taskén, Jahnsen, Orstavik: "Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450." in: The EMBO journal, Vol. 18, Issue 7, pp. 1858-68, (1999) (PubMed).

Lin, Wyszynski, Madhavan, Sealock, Kim, Sheng: "Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 18, Issue 6, pp. 2017-27, (1998) (PubMed).

Details zu AKAP9

Target: AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))

Andere Bezeichnung: AKAP450 (AKAP9 Produkte)

Synonyme: AKAP-9 antikoerper, AKAP350 antikoerper, AKAP450 antikoerper, CG-NAP antikoerper, HYPERION antikoerper, LQT11 antikoerper, MU-RMS-40.16A antikoerper, PPP1R45 antikoerper, PRKA9 antikoerper, YOTIAO antikoerper, 5730481H23Rik antikoerper, AW545847 antikoerper, C79026 antikoerper, mKIAA0803 antikoerper, Gisp antikoerper, Yotiao antikoerper, AKAP9 antikoerper, wu:fj02h02 antikoerper, prka9 antikoerper, yotiao antikoerper, akap350 antikoerper, akap450 antikoerper, hyperion antikoerper, AKAP120 antikoerper, A-kinase anchoring protein 9 antikoerper, A kinase (PRKA) anchor protein (yotiao) 9 antikoerper, A kinase (PRKA) anchor protein 9 antikoerper, A-kinase anchoring protein AKAP120 antikoerper, AKAP9 antikoerper, Akap9 antikoerper, akap9 antikoerper, CpipJ_CPIJ006715 antikoerper, CpipJ_CPIJ017436 antikoerper

Hintergrund: Compartmentalization of the type II cAMP-dependent protein kinase (PKA) within the cell is essential for its discrete physiological effects. PKA localization is mediated by interactions between the regulatory (RII) subunit and A-kinase anchoring proteins (AKAPs) which position PKA in close proximity to relevant substrates. Some AKAPs exhibit tissue specific expression, while others are detected ubiquitously. AKAP450 localizes PKA type II to centrosomes. The N-terminal portion of AKAP450 (amino acids 1-1626) is almost identical to the Yotiao protein (~210 kDa), an AKAP that localizes PKA to NMDA receptors. In addition, AKAP450 contains three major regions (cc1, cc2, cc3) of coiled coil structures, which are characteristic features of centrosomeal proteins. It is expressed at low levels in multiple tissues, including skeletal muscle and liver, but is highly expressed in kidney. PKA is thought to be involved in the maintenance of the interphase microtubule network and to be necessary for stabilization of minus-end microtubules that originate from the centrosome. Thus AKAP450 may serve as a scaffolding protein to localize PKA and other signaling molecules together in cetrosomes. This antibody is routinely tested by western blot analysis.

Molekulargewicht: 450 kDa

Pathways: M Phase, SARS-CoV-2 Protein Interaktom